149 related articles for article (PubMed ID: 9738589)
1. Recommended guidelines for the treatment of chemotherapy-induced diarrhea.
Wadler S; Benson AB; Engelking C; Catalano R; Field M; Kornblau SM; Mitchell E; Rubin J; Trotta P; Vokes E
J Clin Oncol; 1998 Sep; 16(9):3169-78. PubMed ID: 9738589
[TBL] [Abstract][Full Text] [Related]
2. [Management of chemotherapy induced diarrhea].
Schultz M; Schölmerich J; Kullmann F
Z Gastroenterol; 2004 Jun; 42(6):527-38. PubMed ID: 15190449
[TBL] [Abstract][Full Text] [Related]
3. Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.
Rosenoff S
Support Care Cancer; 2004 Aug; 12(8):561-70. PubMed ID: 15160318
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.
Hoff PM; Saragiotto DF; Barrios CH; del Giglio A; Coutinho AK; Andrade AC; Dutra C; Forones NM; Correa M; Portella Mdo S; Passos VQ; Chinen RN; van Eyll B
J Clin Oncol; 2014 Apr; 32(10):1006-11. PubMed ID: 24516038
[TBL] [Abstract][Full Text] [Related]
5. Octreotide in chemotherapy induced diarrhoea in colorectal cancer: a review article.
Bhattacharya S; Vijayasekar C; Worlding J; Mathew G
Acta Gastroenterol Belg; 2009; 72(3):289-95. PubMed ID: 19902860
[TBL] [Abstract][Full Text] [Related]
6. Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy.
Keefe DM; Elting LS; Nguyen HT; Grunberg SM; Aprile G; Bonaventura A; Selva-Nayagam S; Barsevick A; Koczwara B; Sonis ST
Cancer Chemother Pharmacol; 2014 Oct; 74(4):675-80. PubMed ID: 25055935
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy induced diarrhea.
Richardson G; Dobish R
J Oncol Pharm Pract; 2007 Dec; 13(4):181-98. PubMed ID: 18045778
[TBL] [Abstract][Full Text] [Related]
8. Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease.
Pai V; Porter K; Ranalli M
Pediatr Blood Cancer; 2011 Jan; 56(1):45-9. PubMed ID: 21108438
[TBL] [Abstract][Full Text] [Related]
9. Overview of chemotherapy-induced diarrhea.
Viele CS
Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 3):2-5. PubMed ID: 14702926
[TBL] [Abstract][Full Text] [Related]
10. Recommended guidelines for the treatment of cancer treatment-induced diarrhea.
Benson AB; Ajani JA; Catalano RB; Engelking C; Kornblau SM; Martenson JA; McCallum R; Mitchell EP; O'Dorisio TM; Vokes EE; Wadler S
J Clin Oncol; 2004 Jul; 22(14):2918-26. PubMed ID: 15254061
[TBL] [Abstract][Full Text] [Related]
11. Octreotide in the treatment of severe chemotherapy-induced diarrhea.
Zidan J; Haim N; Beny A; Stein M; Gez E; Kuten A
Ann Oncol; 2001 Feb; 12(2):227-9. PubMed ID: 11300329
[TBL] [Abstract][Full Text] [Related]
12. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
Rosenoff SH
Eur J Cancer Care (Engl); 2004 Sep; 13(4):380-3. PubMed ID: 15305907
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
Rosenoff SH; Gabrail NY; Conklin R; Hohneker JA; Berg WJ; Warsi G; Maloney J; Benedetto JJ; Miles EA; Zhu W; Anthony L
J Support Oncol; 2006 Jun; 4(6):289-94. PubMed ID: 16805331
[TBL] [Abstract][Full Text] [Related]
14. Management of cancer treatment-related diarrhea. Issues and therapeutic strategies.
Kornblau S; Benson AB; Catalano R; Champlin RE; Engelking C; Field M; Ippoliti C; Lazarus HM; Mitchell E; Rubin J; Stiff PJ; Vokes E; Wadler S
J Pain Symptom Manage; 2000 Feb; 19(2):118-29. PubMed ID: 10699539
[TBL] [Abstract][Full Text] [Related]
15. Diarrhea and the rationale to use Sandostatin.
Peeters M; Van den Brande J; Francque S
Acta Gastroenterol Belg; 2010; 73(1):25-36. PubMed ID: 20458847
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy-induced diarrhea].
Kobayashi K
Gan To Kagaku Ryoho; 2003 Jun; 30(6):765-71. PubMed ID: 12852342
[TBL] [Abstract][Full Text] [Related]
17. Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial.
Cascinu S; Fedeli A; Fedeli SL; Catalano G
J Clin Oncol; 1993 Jan; 11(1):148-51. PubMed ID: 8418225
[TBL] [Abstract][Full Text] [Related]
18. Role of octreotide in post chemotherapy and/or radiotherapy diarrhea: prophylaxis or therapy?
Sun JX; Yang N
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e108-13. PubMed ID: 23297685
[TBL] [Abstract][Full Text] [Related]
19. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
Topkan E; Karaoglu A
Oncology; 2006; 71(5-6):354-60. PubMed ID: 17873499
[TBL] [Abstract][Full Text] [Related]
20. Variations in the management of diarrhoea induced by cancer therapy: results from an international, cross-sectional survey among European oncologists.
Kordes M; Gerling M
ESMO Open; 2019; 4(6):e000607. PubMed ID: 31803505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
